# Evaluation of Intravenous Infusion of Labetalol Versus Magnesium Sulfate

> **NCT04539379** · NA · COMPLETED · sponsor: **Zagazig University** · enrollment: 60 (actual)

## Conditions studied

- Magnesium Sulfate
- Labetalol

## Interventions

- **DRUG:** Magnesium sulfate
- **DRUG:** Labetolol

## Key facts

- **NCT ID:** NCT04539379
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-01
- **Primary completion:** 2022-02-01
- **Final completion:** 2022-03-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04539379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04539379, "Evaluation of Intravenous Infusion of Labetalol Versus Magnesium Sulfate". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04539379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*